Company intelligence
Encoded Therapeutics Inc.
About Encoded Therapeutics Inc.
Encoded Therapeutics is creating one-time, disease-modifying gene therapies for pediatric central nervous system (CNS) disorders with its cell-selective targeting and regulation platform. The Encoded approach offers potentially unprecedented gene specificity and cell selectivity to unlock novel opportunities by targeting a range of disease mechanisms. Encoded’s technology is compatible with any delivery system to control where and when therapeutic transgenes are expressed, thereby shaping the functionality of target cells and holding broader therapeutic potential beyond CNS disorders. For more information, please visit www.encoded.com, and follow us on LinkedIn, Twitter @EncodedTx and YouTube. Social media guidelines: https://encoded.com/social-media-community-guidelines/
Verified activity
Signals from Encoded Therapeutics Inc.
3 published signals
Partnerships
Encoded Therapeutics Inc. is working with n-Lorem Foundation, Tristan Sands, and the KCNQ2 Cure Alliance to follow up on a milestone after 8 years of working towards it.
Reported by Brooke Babineau
Research & Knowledge
Encoded Therapeutics Inc. announced that Professor Ingrid Scheffer will share new Phase 1/2 data from the ongoing POLARIS clinical program evaluating ETX101 during a platform presentation at EEC2026 on September 7.
Reported by Encoded Therapeutics Inc.
Research & Knowledge
Encoded Therapeutics Inc. announced that Professor Ingrid Scheffer will share new Phase 1/2 data from the ongoing POLARIS clinical program evaluating ETX101 during a platform presentation at EEC2026 on September 7.
Reported by Encoded Therapeutics Inc.